Results 181 to 190 of about 96,199 (216)
Some of the next articles are maybe not open access.

Allogeneic stem cell transplantation for Glanzmann thrombasthenia

Pediatric Blood & Cancer, 2008
AbstractGlanzmann thrombasthenia (GT) is a rare autosomal recessive bleeding disorder characterized by normal platelet count, but lack of platelet aggregation. The molecular basis is linked to quantitative and/or qualitative abnormalities of the membrane glycoprotein IIb/IIIa complexes. Usually it is associated with mild bleeding but may lead to severe
M Kashif, Ishaqi   +6 more
openaire   +2 more sources

Allogeneic stem cell transplantation for treatment of immunodeficiency

Springer Seminars in Immunopathology, 2004
Primary immunodeficiencies constitute a group of highly complex congenital disorders commonly characterized by an extremely poor prognosis. Allogeneic hematopoietic stem cell transplantation has the potential to establish a permanently functioning immune system and represents a curative approach in many of these disorders.
Wilhelm, Friedrich, Susanna M, Müller
openaire   +2 more sources

Allogeneic Stem Cell Transplantation

2003
Part I. Historical Perspective Hematopoietic Stem Cell Transplantation: A Historical Perspective Frederick R. Appelbaum Part II. Disease Indications: Allogeneic Transplantation Allogeneic Hematopoietic Cell Transplantation for Adult Patients with Acute Myelogenous Leukemia Henry C. Fung and Stephen J.
openaire   +1 more source

ALLOGENEIC STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA

Hematology/Oncology Clinics of North America, 1997
High-dose chemotherapy (with or without total body irradiation) followed by allogenic marrow transplantation is curative for some patients with advanced multiple myeloma. A relatively high transplant-related mortality, however, limits the wider application of this approach.
W I, Bensinger, D, Buckner, G, Gahrton
openaire   +2 more sources

Allogeneic hematopoietic stem cell transplantation for myelofibrosis

Current Opinion in Hematology, 2006
This review summarizes the current status and new developments in allogeneic hemopoietic stem cell transplantation strategies for patients with myelofibrosis with myeloid metaplasia, focusing on novel concepts of allogeneic transplantation with reduced-intensity conditioning.No substantial progress has been made in the conventional management of ...
Giovanni, Barosi, Andrea, Bacigalupo
openaire   +2 more sources

Allogeneic Stem Cell Transplantation

2013
The survival of patients with multiple myeloma (MM) has improved over the past decade [1]. The most significant gains have been in patients without high-risk molecular markers. Despite these gains, multiple myeloma remains fatal and curative strategies are needed.
openaire   +1 more source

Adenovirus infection after allogeneic stem cell transplantation

Leukemia and Lymphoma, 2007
Peter Lang   +2 more
exaly  

Home - About - Disclaimer - Privacy